Dactolisib Tosylate
CAS: 1028385-32-1
Rif. 3D-DRB38532
1mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione | ||
100mg | Fuori produzione | ||
250mg | Fuori produzione | ||
500mg | Fuori produzione |
Informazioni sul prodotto
Dactolisib Tosylate is a synthetic compound that is being investigated as an antineoplastic agent. It inhibits the PI3K/mTOR pathway and has been shown to inhibit cell growth in vitro and induce apoptosis in acute lymphoblastic leukemia cells. Dactolisib Tosylate has also been shown to inhibit the secretase enzyme, which may be a potential treatment for Alzheimer's disease.